Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Background. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 Canadian patients with Clostridium difficile infection (CDI), based on data from 2 randomized, clinical trials. Methods. Patients received fidaxomicin or vancomycin 1. Patients were assessed for clinical response...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Can J Infect Dis Med Microbiol
Autori principali: Lee, Christine, Louie, Thomas J., Weiss, Karl, Valiquette, Louis, Gerson, Marvin, Arnott, Wendy, Gorbach, Sherwood L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2016
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4904592/
https://ncbi.nlm.nih.gov/pubmed/27366179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8048757
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi